Clinical Trials
2 trialsNCT01540461 2014-07-08
Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
Bristol-Myers Squibb
Phase 1 Completed
NCT00437424 2011-05-04
A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction
Bristol-Myers Squibb
Phase 1 Completed